Neuberger Berman Group »

Enliven Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.4M 62k 39.20

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Nextera Energy Common (NEE)
Home Depot Common (HD)
Exxon Mobil Corp Common (XOM)
Asml Holding Adr Representing Nv Common (ASML)

View all positions for Neuberger Berman Group

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Polar Capital Holdings
BlackRock
Commodore Capital
Vestal Point Capital
Bellevue Group
Citadel Advisors
Fairmount Funds Management
VR Adviser
Novo A/S
State Street Corporation
Geode Capital Management
Logos Global Management
Caption Management

View all funds holding Enliven Therapeutics